Results 21 to 30 of about 64,260 (308)
Graves' Disease Affecting one Thyroid lobe (Unilateral Graves' Disease): Case Report [PDF]
Egyptian Journal of Nuclear Medicine, 2010 We report a 63-year-old male who was referred to nuclear medicine unit for thyroid scanning with provisional diagnosis of Graves' disease. The patient presented to endocrinology clinic few days before referral with clinical features of heart failure and ...
Sherin Wagih
doaj +1 more source
Updates in the Management of Graves Disease in Children
The Ewha Medical Journal, 2023 Graves disease (GD) is the primary cause of hyperthyroidism in children. The standard management options—namely, antithyroid drugs (ATD), radioactive iodine, and surgery—have not changed for many years.
Yun Jeong Lee
doaj +1 more source
Minimal change disease associated with Graves’ disease and methimazole use
Revista Colombiana de Nefrología, 2022 Introduction. Graves' disease causes kidney injury through multiple mechanisms, including the treatment for this condition. Nephrotic syndrome due to minimal change disease (MCD) is an unusual form of such kidney injury; the association between ...
Andrés Fernando Rodríguez-Gutiérrez +1 more
doaj +1 more source
Antithyroid Drug Treatment in Graves’ Disease [PDF]
Endocrinology and Metabolism, 2021 Graves’ disease is associated with thyrotropin (TSH) receptor stimulating antibody, for which there is no therapeutic agent. This disease is currently treated through inhibition of thyroid hormone synthesis or destruction of the thyroid gland. Recurrence
Jae Hoon Chung
doaj +1 more source
Immunoglobulin G4-Related Thyroid Disease: A Single-Center Experience and Literature Review [PDF]
Endocrinology and Metabolism, 2022 Background Immunoglobulin G4 (IgG4)-related disease is an entity that can involve the thyroid gland. The spectrum of IgG4-related thyroid disease (IgG4-RTD) includes Hashimoto thyroiditis (HT) and its fibrotic variant, Riedel thyroiditis, as well as ...
Meihua Jin +7 more
doaj +1 more source
Clinical Outcomes of Repeated Radioactive Iodine Therapy for Graves’ Disease [PDF]
Endocrinology and Metabolism, 2022 Background Radioactive iodine (RAI) therapy is a successful therapeutic modality for Graves’ disease. However, RAI therapy can fail, and RAI therapy after antithyroid drugs (ATDs) has a lower remission rate.
Min Joo Kim +6 more
doaj +1 more source
Archives of Endocrinology and Metabolism, 2020 Objective Graves’ disease (GD) is the main cause of hyperthyroidism among adults. It is an autoimmune condition classically marked by the Merserburg Triad (goiter, thyrotoxicosis, and orbitopathy), but the change in presentation of GD over time has ...
Wanesa Pinto +4 more
doaj +1 more source
The Indonesian Journal of Gastroenterology, Hepatology and Digestive Endoscopy, 2022 Graves' disease is an autoimmune thyroid disease with several characteristic symptoms and signs. Graves' ophthalmopathy, an inflammatory disease in the orbital area, is the main extrathyroid manifestation of Graves' disease.
Herry Krisnata Ginting, Soebagijo Adi
doaj +1 more source
Programmed Cell Death-Ligand 1 (PD-L1) gene Single Nucleotide Polymorphism in Graves’ Disease and Hashimoto’s Thyroiditis in Korean Patients [PDF]
Endocrinology and Metabolism, 2021 Background Programmed cell death-ligand 1 (PD-L1) has an important role in regulating immune reactions by binding to programmed death 1 (PD-1) on immune cells, which could prevent the exacerbation of autoimmune thyroid disease (AITD).
Jee Hee Yoon +7 more
doaj +1 more source
Switching of Hashimoto Thyroiditis Into Graves’ Disease: A Case Report and Literature Review [PDF]
Disease and Diagnosis, 2021 Background: Hashimoto thyroiditis (HT) and Graves’ disease (GD) are autoimmune inflammatory thyroid disorders. The evolution from GD into HT is the most common scenario while the conversion from HT into GD seems to be less common. Case Presentation: A 20-
Rajab Maksoud +3 more
doaj +1 more source